A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
This paper provides a brief review of the history, proposed pharmacological mechanisms, safety issues, and clinical applications of the medicine 3,4-methylenedioxymethamphetamine (MDMA). Most clinical MDMA research in patients to date has focused on MDMA-assisted psychotherapy to treat posttraumatic...
Main Authors: | Ben Sessa, Laurie Higbed, David Nutt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00138/full |
Similar Items
-
MDMA-Assisted Therapy for Treatment-Resistant Posttraumatic Stress Disorder (PTSD) – One step further toward a patient-centered treatment pathway
by: S. Pratas Penedos, et al.
Published: (2022-06-01) -
Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
by: J. Sá Couto, et al.
Published: (2022-06-01) -
Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report
by: Tianyi Hui, et al.
Published: (2023-09-01) -
The use of 3,4-Methylenedioxymethamphetamine (MDMA) in the treatment of Post-Traumatic Stress Disorder (PTSD) - review
by: Karol Womperski, et al.
Published: (2023-08-01) -
A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
by: João Paulo Capela, et al.
Published: (2022-01-01)